Literature DB >> 1254995

Chemical characterization of the structure of cholera toxin and its natural toxoid.

A Kurosky, D E Markel, B Touchstone, J W Peterson.   

Abstract

Acrylamide gel electrophoresis demonstrated that the toxin of Vibrio cholerae is comprised of three polypeptide chains, alpha, beta, and gamma, of molecular weights 24,000, 9,700, and 9,700 daltons, respectively. Amino acid sequence analysis of intact toxin indicated a molecular composition of alpha gamma beta4. Acrylamide gel electrophoresis and sequence analysis confirmed that the natural toxoid (choleragenoid) is identical to the toxin beta-chain. The alpha- and gamma-chains of the toxin are disulfide-linked (fragment A) but are noncovalently bound to the beta-chains. About 50% of the primary structure of the N-terminal portion of the beta-chain has been identified and a small segment of the D-terminus has also been characterized. Twenty residues of the N-terminal portions of the alpha- and gamma-chains have been tentativly identified. The amino acid composition of the beta-chain was determined and compared to that of the natural toxoid.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1254995     DOI: 10.1093/infdis/133.supplement_1.s14

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  3 in total

1.  Modulation of fluid absorption and the secretory response of rat jejunum to cholera toxin by dietary fat.

Authors:  F A Sagher; J A Dodge; R Moore; C McMaster; G McCaughey
Journal:  Gut       Date:  1990-11       Impact factor: 23.059

2.  Overlapping genes in the heat-labile enterotoxin operon originating from Escherichia coli human strain.

Authors:  T Yamamoto; T Tamura; T Yokota; T Takano
Journal:  Mol Gen Genet       Date:  1982

3.  The protease from Vibrio cholerae nicks arginine at position 192 from the N-terminus of the heat-labile enterotoxin a subunit from enterotoxigenic Escherichia coli.

Authors:  Y Ichinose; T Tsuji; M Ehara; A Miyama; T Naito
Journal:  Eur J Epidemiol       Date:  1992-09       Impact factor: 8.082

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.